Clinical Trials in Detroit

Showing 19161-19180 of 19,719 trials

A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

NCT00118768

This Phase II study is being conducted in treatment-naive patients (no previous antiviral therapy for Hepatitis C infection) with genotype-1 chronic hepatitis C to evaluate the safety and effectiveness of valopicitabine alone and together with Pegylated Interferon (a drug approved by the Food and Drug Administration for the treatment of Hepatitis C infection).

Chronic Hepatitis C

Merck Sharp & Dohme LLC175 participantsStarted Aug 2005

Phoenix, Arizona, United States • San Diego, California, United States • San Mateo, California, United States +16 more locations

COMPLETEDPhase 1< 1 mile

Carmustine in Treating Patients With Recurrent Malignant Glioma

NCT00004028

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of carmustine in treating patients who are undergoing surgery for recurrent malignant glioma.

Brain and Central Nervous System Tumors

National Cancer Institute (NCI)Started Sep 1996

Birmingham, Alabama, United States • Tampa, Florida, United States • Atlanta, Georgia, United States +6 more locations

A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

Carmustine in Treating Patients With Recurrent Malignant Glioma

Find Trials by Condition in Detroit

Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Functional Circuit Training in Older Adults With Congestive Heart Failure

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology

Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD

BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers

An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients

Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing

Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

CPG 7909 Injection in Non-Small Cell Lung Cancer

An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)

Safety and Efficacy of Laparoscopic Truncal Vagotomy for the Treatment of Obesity

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients

The HIP Impact Protection Program (HIP PRO)

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder